(Q43152056)

English

Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study

scientific article published on 24 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Flecainide for cardioversion in patients at elevated cardiovascular risk and persistent atrial fibrillation: a prospective observational study (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1 reference

based on heuristic

inferred from title

atrial fibrillation

1 reference

based on heuristic

inferred from title

author name string

Fikret Er

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Orhan Aslan

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Evren Caglayan

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Natig Gassanov

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Amir M Nia

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Erland Erdmann

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Stephan Rosenkranz

7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

publication date

24 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Clinical Research in Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

369-373

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

https://scigraph.springernature.com/pub.10.1007/s00392-010-0129-7

0 references

Long-term prognosis after cardioversion of the first episode of symptomatic atrial fibrillation: a condition believed to be benign revised

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic impact of successful cardioversion of atrial fibrillation in patients with organic heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of pretreatment with intravenous flecainide on efficacy of external cardioversion of persistent atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of dronedarone on cardiovascular events in atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of flecainide for the reversion of acute onset atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20180126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00392-010-0129-7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43152056&oldid=1982302470"